Homepage > Company > Media > Pharma News > 2019 > Teva partners with Israeli institutes for early-stage drug research

Teva partners with Israeli institutes for early-stage drug research

JERUSALEM (Reuters) - Teva Pharmaceutical Industries on Monday signed research agreements with two leading Israeli academic institutes, a move to boost its early-stage drug development with a focus on cancer treatments.

The world’s largest generic drugmaker has been looking to expand its specialty portfolio and said it is seeking more than 400 new laboratories within Israeli academia.

A partnership with Tel Aviv University will focus on research and development in cancer and brain studies, while a collaboration with the Weizmann Institute of Science will try to identify antibodies for cancer treatment, Israel-based Teva said.

“Teva is planning to carry out much more cutting-edge collaboration with researchers from leading universities and medical centers in Israel in the fields of oncology, immunology and brain studies - areas in which Israel has unique research capabilities,” said Steffen Nock, head of Teva’s innovative research team.

NOVEMBER 25, 2019

https://www.reuters.com/

Read also

Eli Lilly's weight loss drug could help sleep apnea patients

Shares of Eli Lilly (LLY) are slightly above their flatline Wednesday morning after the pharmaceutical giant announced positive results from a clinical trial of GLP-1 its weight loss drug Zepb...

Essential Pharma acquires Reminyl from Janssen Pharmaceutica

Speciality pharmaceutical group Essential Pharma has concluded the acquisition of Reminyl (Galantamine) oral capsules from Johnson & Johnson company Janssen Pharmaceutica.

GSK Announces FDA Acceptance of New Meningococcal Jab BLA

GSK plc GSK announced that the FDA has accepted its biologics license application (BLA) seeking approval of its 5-in-1 meningococcal ABCWY vaccine candidate, MenABCWY. The FDA has granted a st...

American Brain Foundation funds research in Lewy body dementia, neuroinflammation

DENVER — The American Brain Foundation is funding research to find a cure for Lewy body dementia and discover breakthroughs in neuroinflammation, the group’s executive director said at the America...